Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left"><i>N</i> (%)</td><td class="align_center">Scenario 1—general</td><td class="align_center">Scenario 2—technical</td><td class="align_center">Scenario 3—parental</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Preference</td><td class="align_center">29 (16%)</td><td class="align_center">53 (29%)</td><td class="align_center">102 (55%)</td></tr><tr><td class="align_left">Overall agreeability</td><td class="align_center">156 (85%)</td><td class="align_center">138 (75%)</td><td class="align_center">154 (84%)</td></tr><tr><td class="align_left">Uncertainty</td><td class="align_center">25 (14%)</td><td class="align_center">26 (14%)</td><td class="align_center">7 (4%)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Scenario preference, agreeability, and uncertainty.</div>

Neurology Research International

tab3

Table 3

Table 3: Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations 

Table 3 | Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations 